IP Library › Granted Patent US 10,768,172
Granted Patent B2
US 10,768,172 · App. 15/331,632 · Granted Sep 8, 2020

Anti-bed bug monoclonal antibodies and methods of making and uses thereof

Inventors: William John Hall (Harrisonburg, VA); Min Wang (San Diego, CA)
Assignee: Redcoat Solutions, Inc.
G01N33/5308C07K16/00C12N5/12C12N5/163G01N33/577B01J13/0043B22F2301/255B22F2304/054B22F2304/056C07K2317/14C07K2317/56C07K2317/565G01N33/558G01N2333/43552
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,768,172
App. No.
15/331,632
Granted
Sep 8, 2020
Kind
B2
Abstract

The present disclosure provides anti-bed bug monoclonal antibodies and antigen-binding fragments thereof as well as compositions and kits comprising the same. The present disclosure also provides methods of making monoclonal antibodies and antigen-binding fragments thereof and methods of using the same to detect bed bugs.

Claims (26)

1. An antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2] or PTA-122645 [BB7], or an antigen-binding fragment thereof.

2. A monoclonal antibody or an antigen-binding fragment thereof comprising the three heavy and three light chain complementarity determining regions of the antibody of claim 1 .

3. The antibody or antigen-binding fragment of claim 2 , comprising the heavy and light chain variable regions of the antibody of claim 1 .

4. The antibody or antigen-binding fragment of claim 3 , comprising the heavy and light chains of the antibody of claim 1 .

5. The antibody or antigen-binding fragment of claim 1 , wherein the antibody or antigen-binding fragment is capable of binding to a bed bug antigen in a lysate of whole bed bugs or an extract of collection paper comprising bed bug waste material.

6. A conjugated monoclonal antibody or conjugated antigen-binding fragment, comprising the antibody or antigen-binding fragment of claim 1 and a detection agent.

7. The conjugated antibody or conjugated antigen-binding fragment of claim 6 , wherein the detection agent is colloidal gold.

8. The conjugated antibody or conjugated antigen-binding fragment of claim 6 , comprising the antibody produced by the hybridoma deposited at the ATCC under Accession Number PTA-122644 [BB2], or an antigen binding fragment thereof.

9. The conjugated antibody or conjugated antigen-binding fragment of claim 6 , comprising the antibody produced by the hybridoma deposited at the ATCC under Accession Number PTA-122645 [BB7], or an antigen binding fragment thereof.

10. A composition comprising the antibody or antigen-binding fragment of claim 1 .

11. A composition comprising:

(a) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2], and

(b) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122645 [BB7], or the conjugated antibody of claim 9 .

12. A composition comprising:

(a) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122645 [BB7], and

(b) an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2], or the conjugated antibody of claim 8 .

13. A kit comprising the antibody or antigen-binding fragment of claim 1 .

14. A hybridoma capable of producing an antibody, wherein the hybridoma is deposited at the ATCC under Accession Number PTA-122644 [BB2] or PTA-122645 [BB7].

15. An isolated cell producing the antibody or antigen-binding fragment of claim 1 .

16. A method of making the antibody or antigen-binding fragment of claim 1 , comprising (a) culturing a cell that produces the antibody or antigen-binding fragment, and (b) isolating the antibody or antigen-binding fragment from the cultured cell.

17. A method of detecting bed bugs, comprising contacting a sample comprising a bed bug antigen with the antibody or antigen-binding fragment of claim 1 , and detecting binding of the bed bug antigen to the antibody or antigen-binding fragment.

18. The method of claim 17 , wherein the detecting comprises performing a lateral flow assay.

19. The method of claim 17 , wherein the method further comprises collecting the sample comprising the bed bug antigen with a collection device and extracting antigens from the sample.

20. The method of claim 19 , wherein the collection device is a swab.

21. A method of detecting bed bugs, comprising contacting a sample comprising a bed bug antigen with an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122644 [BB2], and the conjugated antibody of claim 9 .

22. A method of detecting bed bugs, comprising contacting a sample comprising a bed bug antigen with an antibody produced by a hybridoma deposited at the American Type Culture Collection (ATCC) under Accession Number PTA-122645 [BB7], and the conjugated antibody of claim 8 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2018
From: HALL, WILLIAM JOHN; WANG, MIN
To: REDCOAT SOLUTIONS, INC.
Reel/Frame 045287/0059 →
Continuity (2)
Provisional Application 62244189 · Oct 21, 2015
Related Publication 20170137501A1 · May 18, 2017